Amgen Clinical Trials Interactive
Learn about Amgen's active cardiometabolic clinical trials in lipid-lowering, Atherosclerotic Cardiovascular Disease (ASCVD) and Obesity.
ACC.21
May 15–17, 2021, Virtual
Amgen is proud to be a part of the American College of Cardiology's 70th Annual Scientific Session & Expo. While you're here, you can explore the latest scientific information and disease state education from Amgen, and learn about Amgen's long-term commitment to developing and delivering transformative medicines for patients with cardiovascular disease.
Cardiometabolic Pipeline
PROFICIO Clinical Development Program—Introducing Vesalius-CV
Learn about PROFICIO, Amgen’s program of clinical studies of evolocumab. Introducing Vesalius-CV, a global initiative exploring the potential of evolocumab for the prevention of first CV events. This is an investigational study. Evolocumab is not indicated for this intended use.
DOWNLOAD BOOKLET
PROFICIO Real-World Evidence (RWE) Generation Booklet
PROFICIO RWE is Amgen's program of real-world evidence studies investigating the impact of evolocumab and use of lipid-lowering therapies across multiple patient populations.
Evolocumab VESALIUS-CV Clinical Trial Card
A double-blind, randomized, placebo-controlled, multicenter study to evaluate the impact of evolocumab on major cardiovascular events in patients at high cardiovascular risk without prior myocardial infarction or stroke. This is an investigational study. Evolocumab is not indicated for this intended use.
Olpasiran (AMG 890) Phase 2 Clinical Trial Card
A Phase 2, double-blind, randomized, placebo-controlled study to evaluate efficacy, safety, and tolerability of olpasiran (AMG 890) in subjects with elevated lipoprotein(a). Olpasiran is an investigational drug. Efficacy and safety have not been established.
Amgen Pipeline Website
Explore Amgen's robust and differentiated pipeline, leveraging state-of-the-art science to create medicines for serious illnesses.
Amgen Clinical Trials
AmgenTrials.com is dedicated to bringing information about Amgen's clinical trials to patients and healthcare communities.
Please note: Some of the information on this page may pertain to investigational drugs.